These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 4154862

  • 21. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K.
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract] [Full Text] [Related]

  • 22. Comparative effects of sotalol and propranolol on myocardial contractility.
    Gomoll AW, Braunwald E.
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):338-54. PubMed ID: 4148833
    [No Abstract] [Full Text] [Related]

  • 23. Assessment of selective beta-adrenoceptor blockade in man.
    Briant RH, Dollery CT, Fenyvesi T, George CF.
    Br J Pharmacol; 1973 Sep; 49(1):106-14. PubMed ID: 4150760
    [Abstract] [Full Text] [Related]

  • 24. A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.
    Kudo Y, Sokabe H, Zehr JE.
    J Pharmacobiodyn; 1981 Jul; 4(7):475-82. PubMed ID: 6117611
    [Abstract] [Full Text] [Related]

  • 25. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
    Meyer RF, Stratton CD, Hastings SG, Corey RM.
    J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
    [No Abstract] [Full Text] [Related]

  • 26. 2-Nitrilophenoxypropanolamines: -adrenoreceptor antagonism in the rat.
    Mylecharane EJ, Raper C.
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):163-70. PubMed ID: 4144370
    [No Abstract] [Full Text] [Related]

  • 27. The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents.
    Adam KR, Baird JR, Burges RA, Linnell J.
    Eur J Pharmacol; 1974 Feb; 25(2):170-5. PubMed ID: 4154851
    [No Abstract] [Full Text] [Related]

  • 28. Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.
    Allely MC, Ungar A.
    Br J Pharmacol; 1985 Oct; 86(2):393-8. PubMed ID: 2864972
    [Abstract] [Full Text] [Related]

  • 29. Letter: Beta receptors and renin release.
    Amery A, Billiet L, Fagard R.
    N Engl J Med; 1974 Jan 31; 290(5):284. PubMed ID: 4148766
    [No Abstract] [Full Text] [Related]

  • 30. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H, Noguchi Y, Nakao K, Takagi K.
    Jpn J Pharmacol; 1974 Apr 31; 24(2):261-70. PubMed ID: 4152803
    [No Abstract] [Full Text] [Related]

  • 31. Beta-adrenolytic, antiarrhythmic and local anaesthetic effects of phenylephrine.
    Reinhardt D, Wagner J.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Apr 31; 284(3):245-61. PubMed ID: 4154414
    [No Abstract] [Full Text] [Related]

  • 32. Beta-receptor blocking and cardiodepressant actions of 2-nitrilophenoxypropanolamines.
    Mylecharane EJ, Raper C.
    Eur J Pharmacol; 1971 Sep 31; 16(1):14-20. PubMed ID: 4400509
    [No Abstract] [Full Text] [Related]

  • 33. The central action of drugs affecting beta-adrenergic receptor. IV. The influence of intraventricularly administered drugs affecting beta-adrenergic receptor on blood pressure in rats.
    Kleinrok Z, Ksiazek A.
    Pol J Pharmacol Pharm; 1975 Sep 31; 27(2):177-82. PubMed ID: 239397
    [Abstract] [Full Text] [Related]

  • 34. Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline.
    Johnsson G, Nyberg G, Sölvell L.
    Acta Pharmacol Toxicol (Copenh); 1975 Sep 31; 36(Suppl 5):69-75. PubMed ID: 1094803
    [No Abstract] [Full Text] [Related]

  • 35. Studies on the temperature-dependent sensitivity of mouse atria to adrenergic drugs.
    Muñoz-Ramírez H, Ryan CF, Buckner CK.
    Eur J Pharmacol; 1975 Jan 31; 30(1):73-8. PubMed ID: 235439
    [Abstract] [Full Text] [Related]

  • 36. Coronary blood flow and hemodynamic effects of beta-adrenoceptor activation and beta-blockade in the baboon.
    Rosendorff C, Rogers GG, Shimell CJ, Coull A, Bomzon L.
    Basic Res Cardiol; 1981 Jan 31; 76(5):545-9. PubMed ID: 6118129
    [No Abstract] [Full Text] [Related]

  • 37. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A, Kostka-Trabka E, Gryglewski R.
    Pol J Pharmacol Pharm; 1973 Jan 31; 25(1):85-90. PubMed ID: 4149575
    [No Abstract] [Full Text] [Related]

  • 38. Practolol blockade of cardiac but not vascular or uterine beta-adrenergic receptors in the anesthetized cat.
    Levy B.
    Arch Int Pharmacodyn Ther; 1973 Jul 31; 204(1):143-6. PubMed ID: 4147749
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacological properties of new 1,2-benzisothiazolyloxypropanolamines on cardiac and tracheal beta-receptors.
    Barocelli E, Chiavarini M, Ballabeni V, Mingiardi MR, Morini G, Ronchini F, Impicciatore M.
    Boll Soc Ital Biol Sper; 1992 Jul 31; 68(7):445-51. PubMed ID: 1362354
    [Abstract] [Full Text] [Related]

  • 40. Studies on the effects of enantiomers of soterenol, trimetoquinol and salbutamol on beta adrenergic receptors of isolated guinea-pig atria and trachea.
    Buckner CK, Abel P.
    J Pharmacol Exp Ther; 1974 Jun 31; 189(3):616-25. PubMed ID: 4152313
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.